Nuveen LLC Invests $502,000 in National Research Corporation $NRC

Nuveen LLC acquired a new position in National Research Corporation (NASDAQ:NRC) during the first quarter, according to its most recent 13F filing with the SEC. The firm acquired 39,235 shares of the company’s stock, valued at approximately $502,000. Nuveen LLC owned 0.17% of National Research at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of NRC. Tower Research Capital LLC TRC raised its holdings in shares of National Research by 376.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,507 shares of the company’s stock worth $44,000 after purchasing an additional 1,981 shares during the period. Significant Wealth Partners LLC purchased a new position in shares of National Research in the 1st quarter worth about $131,000. M&T Bank Corp purchased a new position in shares of National Research in the 1st quarter worth about $164,000. Jane Street Group LLC raised its holdings in shares of National Research by 8.6% in the 4th quarter. Jane Street Group LLC now owns 10,605 shares of the company’s stock worth $187,000 after purchasing an additional 840 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of National Research by 45,978.8% during the 1st quarter. GAMMA Investing LLC now owns 15,206 shares of the company’s stock valued at $195,000 after buying an additional 15,173 shares during the period. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

National Research Stock Performance

Shares of NASDAQ:NRC opened at $14.96 on Friday. National Research Corporation has a one year low of $9.76 and a one year high of $22.99. The business’s 50-day simple moving average is $15.07 and its 200 day simple moving average is $14.27. The company has a debt-to-equity ratio of 3.61, a quick ratio of 0.70 and a current ratio of 0.70. The company has a market cap of $344.98 million, a P/E ratio of 19.68 and a beta of 0.47.

National Research (NASDAQ:NRC) last issued its quarterly earnings data on Monday, July 28th. The company reported $0.28 earnings per share for the quarter. National Research had a return on equity of 83.52% and a net margin of 12.78%.The firm had revenue of $34.04 million during the quarter.

National Research Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date is Friday, September 26th. National Research’s dividend payout ratio (DPR) is 63.16%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.